(1R,2S,4S,5S,8R,9R,10S,11S,12R,14S,16R)-11-[(2S,3S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-5-ethyl-16-hydroxy-9-[(2S,4S,5R,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-3,6,15-trioxatricyclo[10.2.1.12,4]hexadecan-7-one

C37H65NO12 — CID 124712684

IUPAC(1R,2S,4S,5S,8R,9R,10S,11S,12R,14S,16R)-11-[(2S,3S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-5-ethyl-16-hydroxy-9-[(2S,4S,5R,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-3,6,15-trioxatricyclo[10.2.1.12,4]hexadecan-7-one
SMILESCC[C@@H]1OC(=O)[C@H](C)[C@H](O[C@@H]2C[C@](C)(OC)[C@H](O)[C@H](C)O2)[C@H](C)[C@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@@H]2O)[C@@]2(C)C[C@H](C)[C@@H](O2)[C@@]2(C)O[C@@]1(C)[C@H]2O
InChIInChI=1S/C37H65NO12/c1-14-24-36(9)33(42)37(10,50-36)29-18(2)16-35(8,49-29)30(48-32-26(39)23(38(11)12)15-19(3)44-32)20(4)27(21(5)31(41)46-24)47-25-17-34(7,43-13)28(40)22(6)45-25/h18-30,32-33,39-40,42H,14-17H2,1-13H3/t18-,19+,20-,21+,22-,23-,24-,25+,26-,27+,28+,29+,30-,32-,33+,34-,35+,36+,37+/m0/s1
InChIKeyBRMNLNCFPIYRKT-ILGXFURESA-N
MW715.92 g/mol
LogP2.78
Rot. Bonds7

About (1R,2S,4S,5S,8R,9R,10S,11S,12R,14S,16R)-11-[(2S,3S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-5-ethyl-16-hydroxy-9-[(2S,4S,5R,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-3,6,15-trioxatricyclo[10.2.1.12,4]hexadecan-7-one

(1R,2S,4S,5S,8R,9R,10S,11S,12R,14S,16R)-11-[(2S,3S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-5-ethyl-16-hydroxy-9-[(2S,4S,5R,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-3,6,15-trioxatricyclo[10.2.1.12,4]hexadecan-7-one (PubChem CID 124712684) has the molecular formula C37H65NO12 and a molecular weight of 715.92 g/mol. Its IUPAC name is (1R,2S,4S,5S,8R,9R,10S,11S,12R,14S,16R)-11-[(2S,3S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-5-ethyl-16-hydroxy-9-[(2S,4S,5R,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-3,6,15-trioxatricyclo[10.2.1.12,4]hexadecan-7-one.

Molecular Properties

Compound Name(1R,2S,4S,5S,8R,9R,10S,11S,12R,14S,16R)-11-[(2S,3S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-5-ethyl-16-hydroxy-9-[(2S,4S,5R,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-3,6,15-trioxatricyclo[10.2.1.12,4]hexadecan-7-one
PubChem CID124712684
Molecular FormulaC37H65NO12
Molecular Weight715.92 g/mol
Exact Mass715.45
IUPAC Name(1R,2S,4S,5S,8R,9R,10S,11S,12R,14S,16R)-11-[(2S,3S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-5-ethyl-16-hydroxy-9-[(2S,4S,5R,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-3,6,15-trioxatricyclo[10.2.1.12,4]hexadecan-7-one
SMILESCC[C@@H]1OC(=O)[C@H](C)[C@H](O[C@@H]2C[C@](C)(OC)[C@H](O)[C@H](C)O2)[C@H](C)[C@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@@H]2O)[C@@]2(C)C[C@H](C)[C@@H](O2)[C@@]2(C)O[C@@]1(C)[C@H]2O
InChIInChI=1S/C37H65NO12/c1-14-24-36(9)33(42)37(10,50-36)29-18(2)16-35(8,49-29)30(48-32-26(39)23(38(11)12)15-19(3)44-32)20(4)27(21(5)31(41)46-24)47-25-17-34(7,43-13)28(40)22(6)45-25/h18-30,32-33,39-40,42H,14-17H2,1-13H3/t18-,19+,20-,21+,22-,23-,24-,25+,26-,27+,28+,29+,30-,32-,33+,34-,35+,36+,37+/m0/s1
InChIKeyBRMNLNCFPIYRKT-ILGXFURESA-N
XLogP2.78
TPSA154.84 Ų
H-Bond Donors3
H-Bond Acceptors13
Rotatable Bonds7
Heavy Atoms50
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500715.92
LogP ≤ 52.78
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1013

Analyze (1R,2S,4S,5S,8R,9R,10S,11S,12R,14S,16R)-11-[(2S,3S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-5-ethyl-16-hydroxy-9-[(2S,4S,5R,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-3,6,15-trioxatricyclo[10.2.1.12,4]hexadecan-7-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1R,2S,4S,5S,8R,9R,10S,11S,12R,14S,16R)-11-[(2S,3S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-5-ethyl-16-hydroxy-9-[(2S,4S,5R,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-3,6,15-trioxatricyclo[10.2.1.12,4]hexadecan-7-one?
The IUPAC name of (1R,2S,4S,5S,8R,9R,10S,11S,12R,14S,16R)-11-[(2S,3S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-5-ethyl-16-hydroxy-9-[(2S,4S,5R,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-3,6,15-trioxatricyclo[10.2.1.12,4]hexadecan-7-one (CID 124712684) is (1R,2S,4S,5S,8R,9R,10S,11S,12R,14S,16R)-11-[(2S,3S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-5-ethyl-16-hydroxy-9-[(2S,4S,5R,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-3,6,15-trioxatricyclo[10.2.1.12,4]hexadecan-7-one.
What is the SMILES notation for (1R,2S,4S,5S,8R,9R,10S,11S,12R,14S,16R)-11-[(2S,3S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-5-ethyl-16-hydroxy-9-[(2S,4S,5R,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-3,6,15-trioxatricyclo[10.2.1.12,4]hexadecan-7-one?
The canonical SMILES for (1R,2S,4S,5S,8R,9R,10S,11S,12R,14S,16R)-11-[(2S,3S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-5-ethyl-16-hydroxy-9-[(2S,4S,5R,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-3,6,15-trioxatricyclo[10.2.1.12,4]hexadecan-7-one is CC[C@@H]1OC(=O)[C@H](C)[C@H](O[C@@H]2C[C@](C)(OC)[C@H](O)[C@H](C)O2)[C@H](C)[C@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@@H]2O)[C@@]2(C)C[C@H](C)[C@@H](O2)[C@@]2(C)O[C@@]1(C)[C@H]2O.
What is the InChIKey of (1R,2S,4S,5S,8R,9R,10S,11S,12R,14S,16R)-11-[(2S,3S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-5-ethyl-16-hydroxy-9-[(2S,4S,5R,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-3,6,15-trioxatricyclo[10.2.1.12,4]hexadecan-7-one?
The InChIKey is BRMNLNCFPIYRKT-ILGXFURESA-N. The full InChI is InChI=1S/C37H65NO12/c1-14-24-36(9)33(42)37(10,50-36)29-18(2)16-35(8,49-29)30(48-32-26(39)23(38(11)12)15-19(3)44-32)20(4)27(21(5)31(41)46-24)47-25-17-34(7,43-13)28(40)22(6)45-25/h18-30,32-33,39-40,42H,14-17H2,1-13H3/t18-,19+,20-,21+,22-,23-,24-,25+,26-,27+,28+,29+,30-,32-,33+,34-,35+,36+,37+/m0/s1.
What are the key properties of (1R,2S,4S,5S,8R,9R,10S,11S,12R,14S,16R)-11-[(2S,3S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-5-ethyl-16-hydroxy-9-[(2S,4S,5R,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-3,6,15-trioxatricyclo[10.2.1.12,4]hexadecan-7-one?
(1R,2S,4S,5S,8R,9R,10S,11S,12R,14S,16R)-11-[(2S,3S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-5-ethyl-16-hydroxy-9-[(2S,4S,5R,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-3,6,15-trioxatricyclo[10.2.1.12,4]hexadecan-7-one has a molecular weight of 715.92 g/mol, XLogP of 2.78, 7 rotatable bonds, 3 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for (1R,2S,4S,5S,8R,9R,10S,11S,12R,14S,16R)-11-[(2S,3S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-5-ethyl-16-hydroxy-9-[(2S,4S,5R,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-3,6,15-trioxatricyclo[10.2.1.12,4]hexadecan-7-one is sourced from PubChem (CID 124712684), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).